Browse Arkansas Code titles and sections
23-79-1703. State and Public School Life and Health Insurance Board — Requirements.
Arkansas Code — all titles (historical 2020) · legal_authorities
23-79-1703. State and Public School Life and Health Insurance Board — Requirements.
(a) By the end of plan year 2017, the State and Public School Life and Health Insurance Board shall explore the evidence supporting opportunities for benefit modification informed by:
(1) The Choosing Wisely Initiative;
(2) Emerging therapies; and
(3) Therapeutic alternatives to invasive surgical procedures, such as regenerative injection therapy.
(b) By July 2018, the board shall:
(1) Identify and consider implementation of pilot programs that include stepped therapy or center of excellence approaches, or both, for which evidence demonstrates cost savings to the plan; and
(2) Identify opportunities to stimulate conversations between patients and providers about appropriate and necessary treatment, including treatment recommendations identified by the Choosing Wisely Initiative.
Source: Arkansas Code — historical release 78 (November 6, 2020) · 23-79-1703
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. A text match is a research starting point; applicability is not established.
Issuing source page ↗
Authority boundary: historical statutory source snapshot not current law.
Open the recorded source website ↗
Record provenance
Stable record: arkansas_code:legal_authorities:23-79-1703
Source file: gov.ar.code.title.23.odt
Pages: Not recorded – Not recorded
Passage SHA-256: a6fb20898560c81fbed18340876f2870f5d4f1e1d9e4bfdb39ba53101e27b119
Source location: content.xml paragraph 48097
Stored source content
23-79-1703. State and Public School Life and Health Insurance Board — Requirements.
(a) By the end of plan year 2017, the State and Public School Life and Health Insurance Board shall explore the evidence supporting opportunities for benefit modification informed by:
(1) The Choosing Wisely Initiative;
(2) Emerging therapies; and
(3) Therapeutic alternatives to invasive surgical procedures, such as regenerative injection therapy.
(b) By July 2018, the board shall:
(1) Identify and consider implementation of pilot programs that include stepped therapy or center of excellence approaches, or both, for which evidence demonstrates cost savings to the plan; and
(2) Identify opportunities to stimulate conversations between patients and providers about appropriate and necessary treatment, including treatment recommendations identified by the Choosing Wisely Initiative.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
No explicit source connection was found. This does not mean there are no relevant authorities.